Fingerprint
Dive into the research topics of 'Rituximab as a dual therapeutic option for pemphigus and primary cutaneous B-cell lymphomas: Two case reports'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab as a dual therapeutic option for pemphigus and primary cutaneous B-cell lymphomas: Two case reports
Andrea Michelerio, Mattia Novario, Stefania Barruscotti, Camilla Vassallo
Research output: Contribution to journal › Article › peer-review